NFL Biosciences SA (EPA:ALNFL)
France · Delayed Price · Currency is EUR 0.3900
-0.0070 (-1.76%)
Nov 12, 2026, 11:17 AM CET
NFL Biosciences Market Cap
NFL Biosciences has a market cap or net worth of €4.94 million as of November 11, 2026. It is the 44,295th most valuable company in the world and the 592nd biggest in France. Its market cap has decreased by 55.68% in one year.
Market Cap
4.94M
Enterprise Value
3.32M
Revenue
3.15K
Global Rank
Country Rank
#592 France
PE Ratio
n/a
ChartMarket Cap Chart
Since July 5, 2021, NFL Biosciences's market cap has decreased from 19.47M to 4.94M, a decrease of -74.62%. That is a compound annual growth rate of -22.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 4.94M | -66.89% |
| Dec 31, 2025 | 14.93M | -21.92% |
| Dec 31, 2024 | 19.12M | 63.78% |
| Dec 29, 2023 | 11.67M | 13.49% |
| Dec 30, 2022 | 10.29M | -18.13% |
| Dec 31, 2021 | 12.56M | -35.48% |
| Jul 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| genOway Société anonyme | 17.61M |
| GenSight Biologics | 17.45M |
| Biophytis | 14.39M |
| Aelis Farma | 11.90M |
| TME Pharma | 10.01M |
| Advicenne | 9.47M |
| Poxel | 8.22M |
| Aton | 5.47M |